Novartis' Kisqali Impresses In Premenopausal Breast Cancer As Market Crowds

 
• By Alexandra Shimmings

Updated data from the MONALEESA-7 study shows the extent of its progression-free survival benefit in premenopausal women with advanced breast cancer; supplemental filings are planned.

Dividing breast cancer cell
• Source: Shutterstock

More from Clinical Trials

More from R&D